4.08
Precedente Chiudi:
$4.06
Aprire:
$4.01
Volume 24 ore:
71,423
Relative Volume:
0.40
Capitalizzazione di mercato:
$44.06M
Reddito:
-
Utile/perdita netta:
$-19.25M
Rapporto P/E:
-2.2921
EPS:
-1.78
Flusso di cassa netto:
$-17.87M
1 W Prestazione:
-9.53%
1M Prestazione:
+5.43%
6M Prestazione:
+2.26%
1 anno Prestazione:
+0.99%
Lantern Pharma Inc Stock (LTRN) Company Profile
Nome
Lantern Pharma Inc
Settore
Industria
Telefono
972-277-1136
Indirizzo
1920 MCKINNEY AVENUE, DALLAS, TX
Confronta LTRN con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LTRN
Lantern Pharma Inc
|
4.08 | 43.85M | 0 | -19.25M | -17.87M | -1.78 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2021-10-07 | Iniziato | H.C. Wainwright | Buy |
Lantern Pharma Inc Borsa (LTRN) Ultime notizie
Detecting support and resistance levels for Lantern Pharma Inc.Quarterly Profit Report & Growth Focused Entry Reports - Newser
Momentum divergence signals in Lantern Pharma Inc. chartJuly 2025 Big Picture & Risk Controlled Daily Plans - Newser
Applying chart zones and confluence areas to Lantern Pharma Inc.Market Risk Summary & Capital Protection Trade Alerts - Newser
Developing predictive dashboards with Lantern Pharma Inc. dataPortfolio Growth Summary & Real-Time Market Trend Scan - Newser
What indicators show strength in Lantern Pharma Inc.July 2025 Opening Moves & Real-Time Buy Signal Alerts - Newser
What technical models suggest about Lantern Pharma Inc.’s comebackForecast Cut & Free Weekly Chart Analysis and Trade Guides - Newser
How to integrate Lantern Pharma Inc. into portfolio analysis tools2025 Price Momentum & Weekly Setup with ROI Potential - Newser
Market reaction to Lantern Pharma Inc.’s recent news2025 Analyst Calls & Weekly Top Gainers Alerts - Newser
Will breakout in Lantern Pharma Inc. lead to full recoveryGap Down & Free Real-Time Volume Trigger Notifications - Newser
Volume spikes in Lantern Pharma Inc. stock – what they meanMarket Trend Review & Weekly Momentum Stock Picks - Newser
Sentiment analysis tools applied to Lantern Pharma Inc.Weekly Investment Summary & Fast Moving Trade Plans - Newser
Will a bounce in Lantern Pharma Inc. offer an exitSwing Trade & High Conviction Investment Ideas - Newser
Key metrics from Lantern Pharma Inc.’s quarterly data2025 Volume Leaders & Fast Entry Momentum Alerts - Newser
Using data tools to time your Lantern Pharma Inc. exitJuly 2025 Trade Ideas & Daily Market Momentum Tracking - Newser
Using Bollinger Bands to evaluate Lantern Pharma Inc.Market Trend Review & Safe Swing Trade Setup Alerts - Newser
Best data tools to analyze Lantern Pharma Inc. stockGap Up & Weekly Return Optimization Plans - Newser
How high can Lantern Pharma Inc. stock goAnalyst Downgrade & Expert Curated Trade Setups - Newser
Custom strategy builders for tracking Lantern Pharma Inc.2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Lantern Pharma To Report NSCLC Data In Asian Never-Smoker Population In September - RTTNews
Automated trading signals detected on Lantern Pharma Inc.Earnings Miss & Weekly High Conviction Trade Ideas - Newser
RedChip to Host Exclusive Investor Webinar Featuring Lantern Pharma on August 26 - The News-Press
Lantern Pharma Unveils AI Module to Predict Cancer Treatment Combination Effectiveness - citybuzz -
Lantern Pharma Inc Azioni (LTRN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):